Genscript Biotech Corporation(01548) Balance Sheet

Quotes

Detailed Quotes

Company Overview

Company Profile Company Executives

Financial Analysis

Main Composition Key Indicators Financial Statement

Multi-dimentional Analyses

Company Valuation Capital Tracking Short Selling Data

Company Overview More

Kingsley Biotechnology Co., Ltd. is a Hong Kong investment holding company mainly engaged in bioscience research and related business. The company operates through four major divisions. The Life Sciences Research Services Division includes gene and peptide synthesis, DNA and nucleic acid primer synthesis, deoxyribonucleic acid sequencing, customized antibody services, protein expression and stable cell line production. The preclinical drug development service division includes protein and antibody engineering, in vitro efficacy research and in vivo efficacy research. The Life Science Research Catalog Product Division provides antibodies, recombinant proteins, protein separation and analysis instruments, molecular biological reagents, peptides, biochemical products and stable cell lines. Industrial synthetic biological products division develops and produces industrial enzymes.

CEO： Jiange Meng

Market： Hong Kong motherboard

Hot List

TradeSearchNews

SymbolLatest price%Chg

Income statement Balance sheet Cash flow

YOY

Do not show

Hide blank lines

(FY)2021/12/31(Q6)2021/06/30(FY)2020/12/31(Q6)2020/06/30

Assets

Current assets

Inventory

39.73% 44.36M 44.28% 34.89M 92.56% 31.75M 64.21% 24.18M

Accounts receivable

0.42% 142.35M 46.55% 92.64M 94% 141.75M 28.02% 63.21M

Advance deposits and other receivables

9.81% 36.05M -23.75% 28.78M 3.84% 32.83M 68.41% 37.75M

Cash and equivalents

87.74% 1.18B 35.51% 957.62M 149.23% 629.06M 149.2% 706.69M

Fixed time deposit-current assets

39.52% 190.09M 23.31% 213.39M -8.37% 136.25M 22.68% 173.05M

Secured deposit

-80.67% 1.44M -19% 2.55M 668.62% 7.47M 1607.61% 3.14M

Financial assets at fair value-current assets

-62.36% 2.21M -96.67% 1.64M -76.94% 5.87M -38.15% 49.43M

Special items of current assets

393.41% 40.49M 1719.96% 39.84M 52.66% 8.21M -- 2.19M

Total current assets

64.92% 1.64B 29.42% 1.37B 79.26% 993.17M 79.22% 1.06B

Non-current assets

Property, plant and equipment

27.42% 439.89M 41.16% 395.25M 46.29% 345.22M 43.93% 280M

Investment property

-10.92% 6.88M -3.4% 7.22M 3.82% 7.73M -1.19% 7.47M

Advance payment

213.44% 18.51M 55.86% 9.25M -31.21% 5.91M -74.97% 5.94M

Associated company interest

-3.35% 3.32M 32.55% 3.32M 31.28% 3.43M -16.11% 2.5M

Fixed time deposit-non-current assets

-- 4.71M -- -- -- -- -- --

Financial assets at fair value-non-current assets

-1.05% 10.44M 101.87% 11.24M 126.16% 10.56M 37.11% 5.57M

Intangible assets

1.55% 26.42M -0.33% 27.26M 2.11% 26.02M 38.7% 27.35M

Goodwill

0.25% 14.15M -7.08% 14.13M -7.41% 14.12M -0.5% 15.21M

Deferred tax assets

37.49% 5.09M -21.85% 3.09M -35.06% 3.7M -77.51% 3.95M

Other illiquid assets

76.48% 6.25M -- 4.22M -- 3.54M -- --

Special items of non-current assets

73.87% 59.15M 29.74% 41.74M 14.76% 34.02M 510.26% 32.17M

Total non-current assets

30.95% 594.81M 35.92% 516.72M 35.44% 454.23M 30.78% 380.17M

Total assets

54.26% 2.23B 31.13% 1.89B 62.74% 1.45B 63.25% 1.44B

Liabilities

Current liabilities

Accounts payable

29.09% 30.18M 19.84% 27.24M 32.61% 23.38M 63.16% 22.73M

Tax payable

76.56% 6.24M 47.71% 5.25M 24.1% 3.53M -39.04% 3.56M

Dividend payable

-- -- -- -- -- -- -- 14.88M

Other payables and accrued expenses

26.33% 213.47M 54.99% 192.08M 35.15% 168.98M 47.31% 123.93M

Bank loans and overdrafts

-98.83% 521K -57.69% 20.55M 162.48% 44.64M 183.13% 48.56M

Financial lease liabilities-current liabilities

190.19% 7.51M 101.7% 4.75M 46.3% 2.59M 70.38% 2.35M

Special items of current liabilities

143.48% 206.46M 173.52% 171.42M 40.81% 84.79M 52.45% 62.67M

Total current liabilities

41.61% 464.37M 51.17% 421.29M 46.06% 327.91M 70.41% 278.69M

Net current assets

76.41% 1.17B 21.65% 950.05M 101.88% 665.26M 82.59% 780.96M

Total assets less current liabilities

57.96% 1.77B 26.32% 1.47B 68.37% 1.12B 61.62% 1.16B

Non-current liabilities

Long-term bank loan

9508.73% 121.07M 1124.88% 18.21M -27.92% 1.26M -27.11% 1.49M

Financial lease liabilities-non-current liabilities

319.91% 27.35M 101.36% 12.3M 80.52% 6.51M 48.56% 6.11M

Deferred tax liability

9.96% 7.73M 27.33% 9.8M 25.94% 7.03M 44.45% 7.7M

Other non-current liabilities

-28.52% 396K -- 554K -- 554K -- --

Special items of non-current liabilities

79.83% 518.9M 2.37% 266.56M 2.44% 288.55M 5.02% 260.38M

Total non-current liabilities

122.26% 675.45M 11.52% 307.43M 3.86% 303.9M 6.27% 275.67M

Total liabilities

80.4% 1.14B 31.45% 728.71M 22.18% 631.82M 31.07% 554.36M

Total assets less total liabilities

34.01% 1.09B 30.93% 1.16B 119.07% 815.59M 92.91% 885.45M

Total equity and non-current liabilities

57.96% 1.77B 26.32% 1.47B 68.37% 1.12B 61.62% 1.16B

Equity

Share capital

7.27% 2.1M 8.5% 2.08M 3.99% 1.95M 3.12% 1.92M

Reserve

-2.52% 893.41M 6.93% 1.03B 135.78% 916.46M 111.02% 958.68M

Legal reserve

-2.52% 893.41M 6.93% 1.03B 135.78% 916.46M 111.02% 958.68M

Special items of shareholders' rights and interests

5.74% -15.75M 5.26% -16.33M -114.97% -16.71M -658.87% -17.23M

Shareholders' Equity

-2.43% 879.75M 7.16% 1.01B 135.55% 901.71M 107.83% 943.36M

Non-controlling interest

347.58% 213.2M 356.39% 148.48M -719.66% -86.11M -1235.94% -57.91M

Total equity

34.01% 1.09B 30.93% 1.16B 119.07% 815.59M 92.91% 885.45M

Total equity and total liabilities

54.26% 2.23B 31.13% 1.89B 62.74% 1.45B 63.25% 1.44B

Currency Unit

USDUSDUSDUSD

Accounting Standards

HKASHKASHKASHKAS

Audit Opinions

Unqualified Opinion--Unqualified Opinion--

Auditor

Ernst & Young accounting firm--Ernst & Young accounting firm--

Q6, Q9, and FY are cumulative quarterly reports: Q6 is the interim report; Q9 is third quarter report; FY is the annual report.

The MOM data from the Quarterly report，MOM=(current period - last period)/last period *100%